{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:47:23Z","timestamp":1791398843536,"version":"4.3.3"},"reference-count":61,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U54 AI 057157"],"award-info":[{"award-number":["U54 AI 057157"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01 AI088250"],"award-info":[{"award-number":["R01 AI088250"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.12.045","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T05:54:10Z","timestamp":1452146050000},"page":"950-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates"],"prefix":"10.1016","volume":"34","author":[{"given":"John T.","family":"Bates","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Pickens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Tollefson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John V.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Schultz-Darken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Slaughter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Smith-House","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.12.045_bib0310","first-page":"1601","article-title":"Respiratory Syncytial Virus and Human Metapneumovirus","volume":"vol. 2","author":"Collins","year":"2007"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0315","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1204630","article-title":"Burden of human metapneumovirus infection in young children","volume":"368","author":"Edwards","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0320","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0325","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa025472","article-title":"Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children","volume":"350","author":"Williams","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0330","first-page":"914","article-title":"Respiratory syncytial virus infection: denominator-based studies in Indonesia, Mozambique, Nigeria and South Africa","volume":"82","author":"Robertson","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0335","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/irv.12234","article-title":"Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults","volume":"8","author":"Widmer","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0340","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/JCM.27.3.589-592.1989","article-title":"Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections","volume":"27","author":"Wagner","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0345","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0350","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0355","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0360","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/oxfordjournals.aje.a120957","article-title":"Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population","volume":"89","author":"Chin","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0365","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0370","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JVI.57.3.721-728.1986","article-title":"Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus","volume":"57","author":"Prince","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0375","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0264-410X(90)90253-I","article-title":"Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3\u20136 months after immunization","volume":"8","author":"Murphy","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0380","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/0264-410X(93)90168-W","article-title":"A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV","volume":"11","author":"Crowe","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0385","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.1128\/JVI.78.16.8753-8760.2004","article-title":"Vbeta14(+) T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV","volume":"78","author":"Johnson","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0390","doi-asserted-by":"crossref","first-page":"13710","DOI":"10.1128\/JVI.01351-07","article-title":"Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats","volume":"81","author":"Mok","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0395","doi-asserted-by":"crossref","first-page":"11410","DOI":"10.1128\/JVI.01688-08","article-title":"An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats","volume":"82","author":"Mok","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0400","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1016\/j.vaccine.2007.07.065","article-title":"Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB\/c mice and functional serum antibodies in rhesus macaques","volume":"25","author":"Elliott","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0405","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1016\/j.vaccine.2012.04.030","article-title":"Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles","volume":"30","author":"Tonkin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0410","doi-asserted-by":"crossref","first-page":"12432","DOI":"10.1128\/JVI.00564-09","article-title":"Acute infection with venezuelan equine encephalitis virus replicon particles catalyzes a systemic antiviral state and protects from lethal virus challenge","volume":"83","author":"Konopka","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0415","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0420","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.181.1.574","article-title":"Nonmucosal alphavirus vaccination stimulates a mucosal inductive environment in the peripheral draining lymph node","volume":"181","author":"Thompson","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0425","doi-asserted-by":"crossref","first-page":"295102","DOI":"10.1088\/0957-4484\/24\/29\/295102","article-title":"Gold nanorod vaccine for respiratory syncytial virus","volume":"24","author":"Stone","year":"2013","journal-title":"Nanotechnology"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0430","doi-asserted-by":"crossref","first-page":"10944","DOI":"10.1128\/JVI.79.17.10944-10951.2005","article-title":"The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity","volume":"79","author":"Williams","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0435","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1128\/JVI.00844-06","article-title":"Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats","volume":"81","author":"Cseke","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0440","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/jiu307","article-title":"A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus","volume":"211","author":"Schuster","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0445","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1128\/JCM.02270-10","article-title":"Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens","volume":"49","author":"Kodani","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0450","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jcv.2012.05.005","article-title":"Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirus","volume":"54","author":"Klemenc","year":"2012","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0455","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/infdis\/171.2.440","article-title":"Systemic immunoprophylaxis of nasal respiratory syncytial virus infection in cotton rats","volume":"171","author":"Sami","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0460","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0168-1702(85)90045-0","article-title":"Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat","volume":"3","author":"Prince","year":"1985","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0465","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1128\/JVI.62.10.3907-3910.1988","article-title":"Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses","volume":"62","author":"Murphy","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0470","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/JVI.70.6.3781-3787.1996","article-title":"A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge","volume":"70","author":"Davis","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0475","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature12442","article-title":"Cross-neutralization of four paramyxoviruses by a human monoclonal antibody","volume":"501","author":"Corti","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0480","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0485","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1473-3099(10)70166-3","article-title":"Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes","volume":"10","author":"Halstead","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0490","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1128\/CVI.00316-10","article-title":"How innate immune mechanisms contribute to antibody-enhanced viral infections","volume":"17","author":"Ubol","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0495","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0500","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/PCC.0b013e3182070990","article-title":"Mortality and morbidity among infants at high risk for severe respiratory syncytial virus infection receiving prophylaxis with palivizumab: a systematic literature review and meta-analysis","volume":"12","author":"Checchia","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0505","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.virol.2014.02.010","article-title":"Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein","volume":"454\u2013455","author":"Bates","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0510","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.4049\/jimmunol.1202964","article-title":"Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency","volume":"190","author":"Bates","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0515","doi-asserted-by":"crossref","first-page":"9682","DOI":"10.1128\/JVI.00715-09","article-title":"Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways","volume":"83","author":"Swedan","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0520","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1089\/vim.2008.0098","article-title":"Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway","volume":"22","author":"Oshansky","year":"2009","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0525","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1128\/JVI.79.9.5353-5362.2005","article-title":"Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines","volume":"79","author":"Spann","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0530","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.virol.2005.09.009","article-title":"Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction","volume":"344","author":"Ramaswamy","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0535","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/JVI.02434-08","article-title":"Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I","volume":"83","author":"Ling","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0540","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1128\/JVI.79.14.9315-9319.2005","article-title":"Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha\/beta interferon responsiveness","volume":"79","author":"Lo","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0545","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1165\/rcmb.2007-0285OC","article-title":"Human metapneumovirus inhibits IFN-alpha signaling through inhibition of STAT1 phosphorylation","volume":"38","author":"Dinwiddie","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0550","doi-asserted-by":"crossref","first-page":"e24496","DOI":"10.1371\/journal.pone.0024496","article-title":"Human metapneumovirus inhibits IFN-beta signaling by downregulating Jak1 and Tyk2 cellular levels","volume":"6","author":"Ren","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0555","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.4049\/jimmunol.0802262","article-title":"Subversion of pulmonary dendritic cell function by paramyxovirus infections","volume":"182","author":"Guerrero-Plata","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0560","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1128\/JVI.00630-08","article-title":"Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells","volume":"82","author":"Munir","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0565","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1513\/pats.200501-011AW","article-title":"New generation live vaccines against human respiratory syncytial virus designed by reverse genetics","volume":"2","author":"Collins","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0570","first-page":"259","article-title":"Live-attenuated respiratory syncytial virus vaccines","volume":"372","author":"Karron","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0575","doi-asserted-by":"crossref","first-page":"e01704","DOI":"10.1128\/mBio.01704-14","article-title":"Refining the balance of attenuation and immunogenicity of respiratory syncytial virus by targeted codon deoptimization of virulence genes","volume":"5","author":"Meng","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0580","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1743-422X-8-36","article-title":"Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines","volume":"8","author":"Naslund","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0585","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1016\/j.vaccine.2008.07.011","article-title":"The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines","volume":"26","author":"Thompson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0590","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.vaccine.2010.02.010","article-title":"Alphavirus replicon-based enhancement of mucosal and systemic immunity is linked to the innate response generated by primary immunization","volume":"28","author":"Tonkin","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0595","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0600","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0605","first-page":"7861","article-title":"Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA","volume":"61","author":"Velders","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2015.12.045_bib0610","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1016\/j.vaccine.2008.05.046","article-title":"Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen","volume":"26","author":"Thompson","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15018423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T17:34:38Z","timestamp":1600018478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15018423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":61,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X15018423"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and efficacy of alphavirus-derived replicon vaccines for respiratory syncytial virus and human metapneumovirus in nonhuman primates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}